Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

The ‘80s were a magical time for heavy metal. But heavy metal belongs on the radio – not in baby formula. Consumer Reports recently tested 41 varieties of infant formula looking for heavy ...

We feel now is a pretty good time to analyse Vertex, Inc.'s ( NASDAQ:VERX ) business as it appears the company may be... Global tax technology provider finds retail consumers want free ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge loss for Vertex given that the company has a more advanced type 1 diabetes ...

Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 32.79 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...

The AICPA endorsed four of the six bills, all of which passed with bipartisan support and were forwarded to the Senate.

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports F1.